Study to Determine the Effectiveness of Risperidone in Bipolar Disorder in Children and Adolescents
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
A clinical study to determine the safety and effectiveness of risperidone compared with
placebo in the treatment of bipolar disorder (manic or mixed type) in children and
adolescents aged 10 to 17 years.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.